We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 472.50
Bid: 470.00
Ask: 475.00
Change: -12.50 (-2.58%)
Spread: 5.00 (1.064%)
Open: 485.00
High: 485.00
Low: 472.50
Prev. Close: 485.00
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

24 Nov 2023 07:00

RNS Number : 5316U
Warpaint London PLC
24 November 2023
 

24 November 2023

 

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

Grant of Options

 

Directors/PDMR Shareholding

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, announces that, on 24 November 2023, it granted 808,500 options ("Options") over Ordinary Shares of 25p each in the Company ("Ordinary Shares") to certain Group employees under the Warpaint London PLC share option schemes. The Options have been granted pursuant to the Company's annual review of remuneration and incentivisation packages.

The Options are exercisable at a price of 325 pence per Ordinary Share, being the closing mid-price on 23 November 2023. The Options are excercisable from 24 November 2026 until 24 November 2033. The Options are not subject to the satisfaction of any performance criteria.

Included within the 808,500 Options granted, the following grants were made to PDMRs:

Position

Number of Options granted

Total number of options held post grant

Summary of options held and grant date

Neil Rodol

Chief Financial Officer

120,000

676,996

306,996 (LTIP)

24,590 (CSOP)

225,410 (non-qualifying)

9,230 CSOP

110,770 (non-qualifying)

21 September 2018

24 May 2021

24 May 2021

 

24 November 2023

24 November 2023

Sally Craig

General Counsel & Company Secretary

10,000

30,000

10,000 (EMI)

10,000 (CSOP)

10,000 (CSOP)

29 June 2017

20 May 2020

24 November 2023

Matthew Goldstein

Managing Director Retra

75,000

225,000

150,000 (non-qualifying)

18,461 CSOP

56,539 (non-qualifying)

24 May 2021

 

24 November 2023

24 November 2023

Following the grant of the 808,500 Options the total number of options in issue over Ordinary Shares is 5,372,699 representing approximately 6.95% of the Company's current issued share capital.

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Neil Rodol

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Warpaint London PLC

b)

LEI

213800EBJ2CN6KIDCO78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25p each

 

 

GB00BYMF3676

b)

Nature of the transaction

Grant of Option

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

325 p

120,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A Single Transaction

e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Outside a Trading Venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sally Craig

2

Reason for the notification

a)

Position/status

General Counsel & Company Secretary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Warpaint London PLC

b)

LEI

213800EBJ2CN6KIDCO78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25p each

 

 

GB00BYMF3676

b)

Nature of the transaction

Grant of Option

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

325 p

10,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A Single Transaction

e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Outside a Trading Venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Goldstein

2

Reason for the notification

a)

Position/status

Managing Director Retra

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Warpaint London PLC

b)

LEI

213800EBJ2CN6KIDCO78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25p each

 

 

GB00BYMF3676

b)

Nature of the transaction

Grant of Option

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

325 p

75,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A Single Transaction

e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Outside a Trading Venue

 

 

 

Enquiries:

Warpaint London

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

 

c/o IFC

 

Shore Capital (Nominated Adviser & Broker)

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

020 7408 4090

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Chandler

020 3934 6630

 

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using its other brand names of Man'stuff, Body Collection and Chit Chat.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFXLLLXFLFFBE
Date   Source Headline
24th Apr 20247:00 amRNSResults for the year ended 31 December 2023
9th Apr 20247:00 amRNSBlock listing Interim Return
9th Apr 20247:00 amRNSTrading Update and Notice of Results
26th Mar 20242:37 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSWard & Hagon Contract Renewal
12th Jan 20247:00 amRNSTrading Update
12th Dec 20237:00 amRNSAppointment of Non-Executive Directors
1st Dec 20233:37 pmRNSTotal Voting Rights
24th Nov 20237:00 amRNSGrant of Options
21st Nov 202311:23 amRNSPDMR Dealing
20th Nov 20231:24 pmRNSHolding(s) in Company
10th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSBlock Listing Interim Return
31st Oct 20237:00 amRNSTotal Voting Rights
13th Oct 20233:38 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20233:26 pmRNSHolding(s) in Company
3rd Oct 202312:25 pmRNSBlocklisting Application
28th Sep 20235:47 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
19th Sep 20233:51 pmRNSHolding(s) in Company
12th Sep 20237:00 amRNSNotice of Results
22nd Aug 202312:31 pmRNSHolding(s) in Company
27th Jul 20234:34 pmRNSHolding(s) in Company
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20231:40 pmRNSResult of AGM
28th Jun 20237:00 amRNSAGM Statement
15th Jun 20237:00 amRNSTrading Update
6th Jun 20237:00 amRNSPDMR Dealings
24th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
9th May 202311:28 amRNSHolding(s) in Company
2nd May 20234:31 pmRNSBlocklisting Application
26th Apr 20237:00 amRNSResults for the year ended 31 December 2022
24th Mar 20237:00 amRNSTrading Update and Notice of Results
14th Feb 202310:16 amRNSAIM Rule 17 Notification
11th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSResignation of Non-Executive Director
14th Oct 20227:00 amRNSRenewal of New Moorcroft House lease at Silsden
21st Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSChange of Adviser
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20222:06 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 202211:05 amRNSSecond Price Monitoring Extn
8th Sep 202211:00 amRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing
28th Jun 20227:00 amRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.